Keele Badge

PHA-30010 - Module Specification
School of Pharmacy and Bioengineering
Faculty of Medicine & Health Sciences

For academic year: 2024/25 Last Updated: 23 November 2024

PHA-30010 - MPharm Programme Stage 3
Coordinator: Alison Cooper Tel: +44 1782 7 33447
Lecture Time: See Timetable...
Level: Level 6
Credits: 120
Study Hours: 1200
School Office:

Programme/Approved Electives for 2024/25

None

Available as a Free Standing Elective

No

Co-requisites

None

Prerequisites

None

Barred Combinations

None

Description for 2024/25

Stage 3 of the MPharm programme has been consolidated into one single 120-credit unit, enabling a continuum of learning that is centred upon the development of key clinical and therapeutic skills. Teaching of therapeutic areas will be fully integrated by inclusion of key pharmacological, chemical and pharmaceutical information related to the subject areas being studied. By the end of Stage 3, MPharm students should be prepared as fully as possible to undertake any summer vacation placements and interviews for foundation training placements.

Aims
This module aims to further develop students core skills in relation to the practice and science of pharmacy in the context of clinical care of patients. Students will also be enabled to explore specialisms within pharmacy, including research and sector-specific practice.

Talis Aspire Reading List
Any reading lists will be provided by the start of the course.
http://lists.lib.keele.ac.uk/modules/pha-30010/lists

Intended Learning Outcomes

Apply a detailed understanding of the statistical and mathematical tools of evidence-based medicine, including epidemiology, to calculate, analyse and draw conclusions from the results of clinical trials and epidemiological studies: 1,3,4,5,7,8
Critically evaluate the available evidence to make informed decisions and solve problems related to patient care: 1,3,4,6,7,8
Apply a systematic and integrated knowledge of underpinning pharmaceutical sciences to the interpretation and implementation of clinical and therapeutic guidelines: 1,3,4,5,7,8
Distinguish between: audit, service evaluation, research and quality improvement: 7
Critically evaluate current research and advanced scholarship in pharmacy, the pharmaceutical sciences and related fields: 1,4,8
Review, consolidate and extend knowledge and understanding of microbiology, medicinal chemistry, pharmacology,¿pharmacogenomics¿and pharmaceutics in the context of current and emerging pharmaceutical care and medicines optimisation: 1,3,4,5,6,7,8
Review, consolidate and extend knowledge and understanding of the properties and applications of drug delivery systems to maximise the therapeutic benefits for patients: 1,3,4,5,6,7,8
Apply an integrated approach to the process of therapeutic decision making in specific population groups, including: children, the elderly, pregnant women and breastfeeding mothers, patients with liver and renal impairment: 1,3,4,7,8
Using an integrated approach, propose treatment plans for patients with specified disease states: 1,3,4,6,7,8
Propose therapeutic management plans incorporating the principles of risk management: 1,4,6,7,8
Demonstrate a systematic understanding of the concepts of public health, health inequalities and health promotion (including the legal and professional framework for accountability) needed to implement and evaluate a health promotion campaign: 2,4,6,7,8
Develop an original health promotion service by drawing on a systematic and integrated knowledge of applied therapeutics in the context of public health: 2
Demonstrate competence in calculations related to evidence-based medicine, clinical pharmacy and pharmaceutics: 3,4,6,7
Communicate effectively, both orally and in writing, in a manner that reflects professional practice appropriate for this level of study: 1,2,4,6,7,8
Apply an in-depth knowledge of decision making processes to ethical problems: 4,6,7
Demonstrate effective leadership and management skills as part of the multi-disciplinary team: 6
Demonstrate competence in appropriate clinical assessment skills for the purposes of clinical management of patients: 6
Obtain informed consent before providing care and pharmacy services: 6

Study hours

The module comprises a rich mixture of different teaching styles, broadly in the following proportions:
Large and small-group teaching sessions: 200 hours
Skills-based practical work and placement activity: 360 hours
Directed private study: 340 hours
Non-directed private study, revision and assessment: 300 hours

School Rules

Students must achieve a minimum overall module mark of 50%, with all SCIMS components passed, to progress to Level M (Stage 4).

Description of Module Assessment

1: Group Assessment weighted 15%
Stage 3 Coursework part 1
Coursework 1 requires students to produce work relating to the management of patient cases. This will include a combination of group tasks, such as presentations and production of reports. An example would be the production of a travel health guide for an allocated country.

2: Group Assessment weighted 10%
Stage 3 Coursework part 2
This component of assessment requires students to work in groups of up to 10 students to design and deliver a health promotion campaign targeted at the local population. The campaign will involve interaction with the public and production of promotional/educational materials such as posters, leaflets and online resources.

3: Assignment weighted 25%
Stage 3 Coursework part 3
This is the third piece of coursework under the name of 'the Therapeutic Framework' and will require students to produce work relating to the management of patient cases. This will be based on students working on their own to produce reports and presentations.

4: Exam weighted 13%
Stage 3 Examination 1
There will be an integrated exam covering content delivered within Semester 1. The exam will comprise of one paper involving short response questions (e.g. Very Short Answer (VSA), Multiple Choice (MCQ), other short answer format questions). (60 mins)

5: Assignment weighted 0%
End of year synoptic assessment
This assessment will comprise of an individual assessment. It will potentially cover all topics studied during the year, but will focus in particular on demonstrating understanding of the integration of those topics.

6: Professional Development weighted 0%
Professional skills development
The Professional Development assessment will include CPD activities, competency assessments (including pharmacy practice skills, calculations, communication skills and placement portfolio of competence), case studies in ethics, and evidence of professionalism measured by Professional Activity Credits.

7: Exam weighted 13%
Stage 3 Examination 2
There will be an integrated exam covering content delivered within Semester 2. The exam will comprise of one paper involving short response questions (e.g. Very Short Answer (VSA), Multiple Choice (MCQ), other short answer format questions). (60 mins)

8: Assignment weighted 24%
Case Based Discussion
An oral assessment based on fictitious case where students are required to answer questions based on their knowledge across the two semesters

The University undertakes a continuous review of its teaching and research provision to ensure programmes are of a high quality and changes may be made to modules where it is necessary and reasonable to do so. Please be aware that minor changes to modules, such as a change to an individual assessment, can occur up until enrolment, although we endeavour to give you as much notice as possible of any changes. Details about the circumstance in which changes are made to programmes can be found in the Student Agreement, available at: https://www.keele.ac.uk/legalgovernancecompliance/governance/actcharterstatutesordinancesandregulations/studenttermsconditions/

Last Updated: 23 November 2024